Suchergebnisse - "JAK inhibitor"

PubPharm (116)

1

Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults : An Open-Label, Phase 1 Study

enthalten in: Journal of clinical pharmacology | 2024

von Martin, D. | Telliez, J. | Pleasic-Williams, S. | +12

2

Design, synthesis, and pharmacological evaluation of quinazoline derivatives as novel and potent pan-JAK inhibitors

enthalten in: Bioorganic chemistry | 2023

von Xiang, J. | Wang, Y. | Wang, W. | +17

3

Cross-Study Comparisons of JAK2 Inhibitors in Myelofibrosis : Risks and Recommendations

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Mascarenhas, J. | Mesa, R.

4

Concurrent bullous pemphigoid and psoriasis vulgaris successfully treated with Janus kinase inhibitor tofacitinib : A case report and review of the literature

enthalten in: International immunopharmacology | 2023

von Li, H. | Wang, H. | Qiao, G. | +3

5

Current application status and structure-activity relationship of selective and non-selective JAK inhibitors in diseases

enthalten in: International immunopharmacology | 2023

von Li, T. | Yang, X. | Zhu, J. | +4

6

Recent progress of JAK inhibitors for hematological disorders

enthalten in: Immunological medicine | 2023

von Kirito, K.

7

Granulomatous reaction to permanent eyebrow makeup successfully treated with oral tofacitinib

enthalten in: Journal of cosmetic dermatology | 2023

von Sun, Y. | Lao, L.

8

Novel Janus-kinase (JAK) Inhibitors in Myelofibrosis

enthalten in: Expert opinion on investigational drugs | 2023

von Ipek, Y. | Kilic, B. | Gunay, U. | +1

9

Targeted Therapy for MPNs : Going Beyond JAK Inhibitors

enthalten in: Current hematologic malignancy reports | 2023

von Chen, E. | Johnston, H. | Patel, A.

10

Symptomatic benefit of momelotinib in patients with myelofibrosis : Results from the SIMPLIFY phase III studies

enthalten in: Cancer medicine | 2023

von Mesa, R. | Hudgens, S. | Floden, L. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]